Phase I study of BTK inhibitor ibrutinib with temozolomide and radiation in newly-diagnosed glioblastoma (EQUILIBRIUM): Final trial report

被引：0
|
作者：
Ahluwalia, Manmeet Singh
Ozair, Ahmad
Khosla, Atulya Aman
Patel, Neha
Elson, Paul
Murphy, Erin Sennett
Yu, Jennifer S.
Chao, Samuel T.
Suh, John H.
Stevens, Glen
Peereboom, David M.
机构：
[1] Baptist Hlth South Florida, Miami Canc Inst, Miami, FL USA
[2] Cleveland Clin, Cleveland, OH USA
[3] Cleveland Clin Fdn, Solon, OH USA
[4] Cleveland Clin, Brunswick Urgent Care, Cleveland, OH USA
[5] Case Western Reserve Univ, Dept Radiat Oncol, Rose Ella Burkhart Brain Tumor & Neuro Oncol Ctr, Cleveland Clin,Lerner Coll Med, Cleveland, OH USA
[6] Cleveland Clin, Dept Radiat Oncol, Taussig Canc Inst, Cleveland, OH USA
[7] Cleveland Clin, Cleveland, OH USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2067
引用
收藏
页数：1
相关论文
共 50 条
  • [1] PHASE I STUDY OF BTK INHIBITOR IBRUTINIB WITH TEMOZOLOMIDE AND RADIATION IN NEWLY-DIAGNOSED GLIOBLASTOMA (EQUILIBRIUM): FINAL TRIAL REPORT
    Ahluwalia, Manmeet
    Ozair, Ahmad
    Khosla, Atulya
    Patel, Neha
    Elson, Paul
    Murphy, Erin
    Chao, Samuel
    Suh, John
    Stevens, Glen
    Peereboom, David
    NEURO-ONCOLOGY, 2023, 25
  • [2] PHASE I STUDY OF IBRUTINIB WITH RADIATION AND TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Ahluwalia, Manmeet
    Patel, Neha
    Khosla, Atulya
    Rauf, Yasmeen
    Stevens, Glen
    Murphy, Erin
    Chao, Samuel
    Yu, Jennifer
    Suh, John
    Peereboom, David
    NEURO-ONCOLOGY, 2022, 24 : 60 - 60
  • [3] PHASE I STUDY OF IBRUTINIB WITH RADIATION AND TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Rauf, Yasmeen
    Peereboom, David
    Fallah, Jaleh
    Schilero, Cathy
    Lackner, Pamela
    Stevens, Glen
    Ahluwalia, Manmeet
    NEURO-ONCOLOGY, 2020, 22 : 37 - 37
  • [4] A PHASE I STUDY OF SORAFENIB WITH RADIATION AND TEMOZOLOMIDE IN NEWLY DIAGNOSED GLIOBLASTOMA
    Colman, Howard
    Gilbert, Mark
    Yung, W. K. Alfred
    Aldape, Ken
    De Groot, John
    Conrad, Charles
    Levin, Victor
    Groves, Morris
    Loghin, Monica
    Chris, Pelloski
    Puduvalli, Vinay
    NEURO-ONCOLOGY, 2011, 13 : 61 - 61
  • [5] PHASE I STUDY OF VANDETANIB WITH RADIATION THERAPY AND TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA
    Drappatz, Jan
    Norden, Andrew
    Wong, Eric T.
    Doherty, Lisa
    LaFrankie, Debra
    Ciampa, Abigail
    Kesari, Santosh
    Sceppa, Christine
    Gerard, Mary
    Phan, Phuong
    Lassman, Andrew B.
    Schiff, David
    Batchelor, Tracy
    Ligon, Keith L.
    Young, Geoffrey
    Muzikansky, Alona
    Weiss, Stephanie
    Wen, Patrick Y.
    NEURO-ONCOLOGY, 2009, 11 (05) : 634 - 634
  • [6] Phase I study of vandetanib with radiation therapy and temozolomide for newly diagnosed glioblastoma
    Drappatz, J.
    Norden, A. D.
    Wong, E. T.
    Lassman, A. B.
    Doherty, L.
    LaFrankie, D.
    Gerard, M.
    Phan, P.
    Schiff, D.
    Wen, P. Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [7] Report of safety of pulse dosing of lapatinib with temozolomide and radiation therapy for newly-diagnosed glioblastoma in a pilot phase II study
    Andrew Yu
    Nadia Faiq
    Stacey Green
    Albert Lai
    Richard Green
    Jethro Hu
    Timothy F. Cloughesy
    Ingo Mellinghoff
    P. Leia Nghiemphu
    Journal of Neuro-Oncology, 2017, 134 : 357 - 362
  • [8] Report of safety of pulse dosing of lapatinib with temozolomide and radiation therapy for newly-diagnosed glioblastoma in a pilot phase II study
    Yu, Andrew
    Faiq, Nadia
    Green, Stacey
    Lai, Albert
    Green, Richard
    Hu, Jethro
    Cloughesy, Timothy F.
    Mellinghoff, Ingo
    Nghiemphu, P. Leia
    JOURNAL OF NEURO-ONCOLOGY, 2017, 134 (02) : 357 - 362
  • [9] Phase II trial of erlotinib with temozolomide and concurrent radiation therapy in patients with newly-diagnosed glioblastoma multiforme.
    Brewer, CJ
    Suh, JH
    Stevens, GHJ
    Barnett, GH
    Toms, S
    Vogelbaum, MA
    Weil, R
    Peereboom, DM
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 130S - 130S
  • [10] A PHASE I TRIAL OF TIPIFARNIB WITH RADIATION THERAPY, WITH AND WITHOUT TEMOZOLOMIDE, FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Nghiemphu, Phioanh Leia
    Wen, Patrick Y.
    Lamborn, Kathleen R.
    Drappatz, Jan
    Robins, H. Ian
    Fink, Karen
    Malkin, Mark G.
    Lieberman, Frank S.
    DeAngelis, Lisa M.
    Torres-Trejo, Alejandro
    Chang, Susan M.
    Abrey, Lauren
    Fine, Howard A.
    Demopoulos, Alexis
    Lassman, Andrew B.
    Kesari, Santosh
    Mehta, Minesh P.
    Prados, Michael D.
    Cloughesy, Timothy F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (05): : 1422 - 1427
12345